Search clinical trials for: This study was completed in October 2006

Total 467680 results

OSF Healthcare System

Completed

Tolerance of Increased Infusion Rates of Intravenous Fat Emulsions in Very Low Birth Weight Infants

Low Birth Weight
Milestone Pharmaceuticals Inc.
IQVIA Biotech

Completed

Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303

Paroxysmal Supraventricular Tachycardia

United States, Argentina, Brazil, Canada, Colombia
GlaxoSmithKline

Completed

Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years

Influenza

Germany
Sohag University

Completed

Analgesia for Thyroidectomy Using Bilateral Superficial Cervical Plexus Block With Bupivacaine Only or Adding Ketorolac to it.

Thyroid Nodule | Thyroid Goiter

Egypt
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effect of Maternal Smoking On Neonatal Lung Function

Lung Diseases, Obstructive | Chronic Obstructive Pulmonary Disease
Society for Gynecological Surgery in Finland
Helsinki University Central Hospital

Completed

Finhyst 2006: Study on Morbidity of Hysterectomies in Finland (Finhyst 2006)

Morbidity of Hysterectomy

Finland
Sanofi Pasteur, a Sanofi Company

Completed

Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine

Influenza

United States
AstraZeneca

Completed

Opinion of Patients Under Treatment That Meets the Criteria of New Treatment Strategy According to GINA 2006 (EPAGGELIA)

New Strategies | GINA 2006 | Patient Opinion

Greece
Seattle Children's Hospital
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age (GRC28)

Inactivated Influenza Vaccine

United States
innoVactiv Inc.

Completed

Effects of 2006-RD-05 on Salivary and Serum Immunoglobulin A (IgA) Levels in Healthy Subjects

Healthy

Canada
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)

Measles | Rubella | Mumps | Varicella
Sanofi

Completed

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

United States
Unity Health Toronto

Completed

HFN Versus NIV in Cystic Fibrosis. The HIFEN Study

Cystic Fibrosis

Canada
BMI Korea

Completed

Treatment of Moderate to Severe Glabellar Lines (BMI2006) (BMI2006)

Glabellar Lines

Korea, Republic of
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of Preservative Free Inactivated Split Influenza Vaccine, Using the Strain Composition 2006/2007 in Non-Elderly Adult and Elderly Subjects

Influenza

Germany
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older

Influenza

Italy
University of British Columbia

Terminated

Post Abortion IUD & Recurrent Abortion 2005-2006

Induced Abortion
Novartis
Novartis Vaccines

Completed

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects

Influenza

Italy
University of Bergen
Helse Vest

Completed

Selective Ultrasound Screening for DDH 1991-2006

Developmental Dysplasia of the Hip

Norway
Assistance Publique - Hôpitaux de Paris

Unknown

Acute Promyelocytic Leukemia 2006 (APL)

Leukemia, Promyelocytic, Acute

France
Sanofi

Completed

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

United States
Sanofi Pasteur, a Sanofi Company

Completed

Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of Age

Influenza

United States
University of Arkansas

Completed

2006-32 Phase II Study of Rapidly Recycled High Dose DTPACE

Multiple Myeloma

United States
GlaxoSmithKline

Completed

Non-Inferiority of Various GSK Bio's Influenza Vaccine Presentations in Adults Aged 65 Years and Over

Influenza

Norway, Estonia, Denmark
Sanofi Pasteur, a Sanofi Company

Completed

A Study of the Immunogenicity and Safety of the 2006-2007 Influenza Vaccine

Influenza | Orthomyxoviridae Infections

Switzerland, United Kingdom
Centre Hospitalier de Cayenne

Completed

Cervical Cancer in French Guiana: Screening Between 2006-2011 (DepCol)

Cervical Cancer

France
Hospital District of Helsinki and Uusimaa

Completed

Deep Brain Stimulation in HUCH Region Between 2006 and 2014

Parkinson's Disease
University of Arkansas

Active, not recruiting

UARK 2006-66, Total Therapy 3B: An Extension of UARK 2003-33 Total Therapy

Multiple Myeloma

United States
University of Arkansas

Withdrawn

UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies

Multiple Myeloma

United States
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine

Influenza

United States
AstraZeneca

Completed

Single Ascending Dose Study (SAD) iv Formulation (2006-006253-27)

Healthy

Sweden
Shahid Beheshti University of Medical Sciences

Completed

The Efficacy of Influenza Vaccination in Patients With Coronary Artery Diseases

Myocardial Infarction | Stable Angina | Coronary Artery Diseases

Iran, Islamic Republic of
GlaxoSmithKline

Completed

Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2006-2007

Infections, Rotavirus
University Hospital, Grenoble

Completed

Severe Legionellosis Cases Admitted to Grenoble University Hospital, 2006-2011. (LEGIOGRE)

Legionnaires' Disease
Shahid Beheshti University of Medical Sciences

Completed

The Efficacy of Influenza Vaccine in Reducing Cardiovascular Events in Patients With Coronary Artery Diseases (IVCAD)

Myocardial Infarction | Stable Angina | Coronary Artery Diseases

Iran, Islamic Republic of
University of Arkansas

Terminated

UARK 2006-15: A Study of Tandem Transplants With or Without Bortezomib and Thalidomide

Multiple Myeloma

United States
Technical University of Munich
University Hospital, Essen; University of Erlangen-Nürnberg; Heinrich-Heine University... and other collaborators

Terminated

Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation (Rituximab 2006)

Renal Transplantation | Transplantation, Kidney | Chronic Allograft Nephropathy | Grafting

Germany
National Institute of Allergy and Infectious Diseases...

Completed

Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally

Influenza

United States
University Psychiatric Clinics Basel
University of Basel

Not yet recruiting

ID-ClimAct. Influence of Social Motives of Clients and Staff on the Social Climate of Secure Settings (ID-ClimAct)

Interpersonal Relations | Social Dominance | Social Environment | Correctional Institutions | Rehabilitation of Criminals

Switzerland
Assistance Publique Hopitaux De Marseille

Completed

Immune Response and Cytomegalovirus in Intensive Care Unit (ICU) Patients (2006/25)

Cytomegalovirus Infection

France
Solvay Pharmaceuticals

Completed

Annual Study to Investigate Inactivated Subunit Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

Healthy Volunteers

Belgium
Solvay Pharmaceuticals

Withdrawn

Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe.

Healthy Volunteers

Germany
National Institute of Allergy and Infectious Diseases...
University of Rochester

Completed

Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus Vaccines

Influenza, Human

United States
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly

Influenza | Orthomyxoviridae Infection | Myxovirus Infection

United States
University Hospital Freiburg

Active, not recruiting

Study for Epidemiology and Characterization of Myelodysplastic Syndromes (MDS) and Juvenile Myelomonocytic Leucemia (JMML) in Childhood (EWOG MDS 2006)

Myelodysplastic Syndromes | Juvenile Myelomonocytic Leukemia

Germany
Instituto Valenciano de Infertilidad, IVI VALENCIA

Completed

Influence of Paternal Age on Assisted Reproduction Outcome (MALE AGING)

We Will Retrospectively Assess Our Databases in Our Clinic | Instituto Valenciano de Infertilidad in Valencia (Spain) | Searching for Assisted Reproduction Procedures | IUI Standard IVF/ICSI Cycles and Ovum Donation IVF/ICSI Cycles | Who Were Referred to Our Unit to Cryopreserve Sperm During... and other conditions

Spain
GlaxoSmithKline

Completed

Study to Evaluate the Safety and Immunogenicity of Fluarix™ 2006/2007 in Adults Aged 18 Years or Above

Influenza

Germany
University Hospital, Clermont-Ferrand

Unknown

Psychiatric Future of Young Patients Hospitalized in the Pass'Aje Service Between 2006 and 2010 (After Pass'Aje)

Psychiatry

France
University of Cologne

Completed

Effect of Red Wine, White Wine and Beer on Contrast-Medium Induced Acute Kidney Injury (RenPro-II-WINE)

Chronic Renal Failure/ Kidney Disease | Contrast-medium Induced Acute Kidney Injury

Germany
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.

Influenza

United States

Search clinical trials for: This study was completed in October 2006

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Philippines

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations